Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth W Mahaffey

Showing results (191-200 of 635) with videos related to

Pageof 64
Sort By:
Circulation|August 20, 2003
Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trialKenneth W Mahaffey, Christopher B Granger, Jose C Nicolau, et al.
Thrombosis Research|March 26, 2004
Evaluation of a novel point-of-care enoxaparin monitor with central laboratory anti-Xa levelsJacqueline Saw, Dean J Kereiakes, Kenneth W Mahaffey, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 31, 2021
Cost-Consequence Analysis of Using Cangrelor in High Angiographic Risk Percutaneous Coronary Intervention Patients: A US Hospital PerspectiveIvar S Jensen, Elizabeth Wu, Philip L Cyr, et al.
American Heart Journal|September 29, 2014
Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary interventionAkshay Bagai, Phillip J Schulte, Christopher B Granger, et al.
JACC. Clinical Electrophysiology|May 17, 2018
Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF RegistryAmbarish Pandey, Bernard J Gersh, Darren K McGuire, et al.
European Heart Journal|June 24, 2005
Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registryKarolina E Szummer, Scott D Solomon, Eric J Velazquez, et al.
Heart (British Cardiac Society)|February 26, 2013
A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trialSergio Leonardi, Adriano A M Truffa, Megan L Neely, et al.
Journal of the American College of Cardiology|June 15, 2004
Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarctionRichard E Waters, Kanwar P Singh, Matthew T Roe, et al.
Stroke|December 29, 2018
Canagliflozin and Stroke in Type 2 Diabetes MellitusZien Zhou, Richard I Lindley, Karin Rådholm, et al.
Circulation|August 1, 2013
Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trialP Gabriel Steg, Robert A Harrington, Håkan Emanuelsson, et al.
Pageof 64

Showing results (191-200 of 635) with videos related to

Sort By:
Pageof 64
Circulation|August 20, 2003
Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trialKenneth W Mahaffey, Christopher B Granger, Jose C Nicolau, et al.
Thrombosis Research|March 26, 2004
Evaluation of a novel point-of-care enoxaparin monitor with central laboratory anti-Xa levelsJacqueline Saw, Dean J Kereiakes, Kenneth W Mahaffey, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 31, 2021
Cost-Consequence Analysis of Using Cangrelor in High Angiographic Risk Percutaneous Coronary Intervention Patients: A US Hospital PerspectiveIvar S Jensen, Elizabeth Wu, Philip L Cyr, et al.
American Heart Journal|September 29, 2014
Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary interventionAkshay Bagai, Phillip J Schulte, Christopher B Granger, et al.
JACC. Clinical Electrophysiology|May 17, 2018
Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF RegistryAmbarish Pandey, Bernard J Gersh, Darren K McGuire, et al.
European Heart Journal|June 24, 2005
Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registryKarolina E Szummer, Scott D Solomon, Eric J Velazquez, et al.
Heart (British Cardiac Society)|February 26, 2013
A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trialSergio Leonardi, Adriano A M Truffa, Megan L Neely, et al.
Journal of the American College of Cardiology|June 15, 2004
Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarctionRichard E Waters, Kanwar P Singh, Matthew T Roe, et al.
Stroke|December 29, 2018
Canagliflozin and Stroke in Type 2 Diabetes MellitusZien Zhou, Richard I Lindley, Karin Rådholm, et al.
Circulation|August 1, 2013
Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trialP Gabriel Steg, Robert A Harrington, Håkan Emanuelsson, et al.
Pageof 64